Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Harding Thomas C. converted options into 300 units of Common Stock and sold $724 worth of Common Stock (148 units at $4.89), increasing direct ownership by 4% to 3,563 units (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.

SEC Form 4: Harding Thomas C. converted options into 300 units of Common Stock and sold $724 worth of Common Stock (148 units at $4.89), increasing direct ownership by 4% to 3,563 units (tax withholding) | Quantisnow